In November, the Food and Drug Administration (FDA) announced that it would soon determine whether Narcan, the nasal spray form of naloxone, is safe for use without a prescription. It planned to fast-track approval within months.
On March 29, the FDA approved Narcan for sale over the counter. The decision is a welcome, but long overdue, change in drug policy.
